Clik here to view.
Genscript Corporation Finishes Year with Successful Hong Kong IPO
PISCATAWAY, N.J. Genscript Biotech Corporation, the number one global provider of gene synthesis services and a strong player in synthetic biology, ended 2015 with a successful IPO of 400,000,000...
View ArticleClik here to view.
Hudson Researcher’s Findings May Improve Cancer Drug Clinical Trial Success...
MELBOURNE, Australia A researcher from Hudson Institute of Medical Research in Melbourne, Australia, has discovered a class of biomarkers which may be used to predict which cancer patients will...
View ArticleClik here to view.
European Commission Approves Label Variation for ADCETRIS® (Brentuximab...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the European Commission (EC) has approved a Type II variation for ADCETRIS® (brentuximab...
View ArticleClik here to view.
ViroMed Publishes Results from Critical Limb Ischemia (CLI) Phase II Clinical...
SEOUL, Korea ViroMed Co., Ltd. (KOSDAQ:084990) has announced the publication of the results from successfully completed phase II clinical study of VM202 for the treatment of critical limb ischemia...
View ArticleClik here to view.
Establishment of Nitto BioPharma, Inc.
OSAKA, Japan Japan’s leading diversified materials manufacturer Nitto Denko Corporation (TOKYO:6988)(ISIN:JP3684000007) established a new company, Nitto BioPharma, Inc., with a focus on...
View ArticleClik here to view.
欧盟核准ADCETRIS® (Brentuximab...
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社 (TSE:4502)今天宣布，欧盟(EC)已核准ADCETRIS® (brentuximab...
View ArticleClik here to view.
Clik here to view.
Agilis Biotherapeutics and National Taiwan University Enter into Worldwide,...
CAMBRIDGE, Mass. Agilis Biotherapeutics, LLC (Agilis), a biotechnology company advancing innovative gene therapies for rare genetic diseases that affect the central nervous system (CNS), announced...
View ArticleClik here to view.
Mersana Therapeutics and Takeda Expand Partnership to Advance Development of...
CAMBRIDGE, Mass. & OSAKA, Japan Mersana Therapeutics and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that they have entered a new strategic partnership granting Takeda...
View ArticleClik here to view.
Mersana Therapeutics與武田擴大夥伴關係，以推動 Fleximer®抗體藥物複合體和XMT-1522的開發
麻薩諸塞州劍橋和日本大阪 (美國商業資訊) — Mersana...
View ArticleClik here to view.
メルサナ・セラピューティクスと武田薬品がFleximer®に基づく抗体薬物複合体とXMT-1522の開発前進に向け提携拡大
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
CORRECTING and REPLACING MEDIA ALERT: CSIRO to Host Silicon Valley Innovation...
PALO ALTO, Calif. Please replace the release dated February 11, 2016 with the following corrected version due to multiple revisions. The corrected release reads: MEDIA ALERT: CSIRO TO HOST SILICON...
View ArticleClik here to view.
PerkinElmer Opens New Diagnostics Facility in Chennai
WALTHAM, Mass. & CHENNAI, India PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, has expanded its footprint in India with the opening...
View ArticleClik here to view.
NuGEN Technologies Announces Commercial Introduction of Ovation® SoLo RNA-Seq...
SAN CARLOS, Calif. NuGEN Technologies, Inc. today announced the launch of the Ovation® SoLo RNA-Seq System, the company’s latest tool in its suite of sample preparation products supporting research...
View ArticleClik here to view.
Strand Life Sciences’ NGS Laboratory First in India to Receive Both CAP and...
BANGALORE, India & DENVER Strand Life Sciences, a global genomic profiling company aimed at empowering personalized cancer care and genetic testing for inherited diseases, announced that its...
View ArticleClik here to view.
Sobi and Biogen Receive Positive Opinion from CHMP for Alprolix® (rFIXFc) for...
STOCKHOLM & CAMBRIDGE, Mass. Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) and Biogen (NASDAQ: BIIB) received a positive opinion from the Committee for Medicinal Products for Human Use...
View ArticleClik here to view.
Prana Biotechnology Half Year Investor Report
MELBOURNE, Australia Prana Biotechnology (ASX:PBT/NASDAQ:PRAN) has released its half year investor report for the six months to December 31, 2015. Results and Review of Operations ResultsThe Group...
View ArticleClik here to view.
Strand Life Sciences Announces Key Publication Demonstrating Clinical Utility...
BANGALORE, India & AURORA, Colo. Strand Life Sciences, a global leader in precision medicine diagnostics, announced the publication of a landmark study in the Journal of Human Genetics in a...
View ArticleClik here to view.
AngioStemTM Inc. Licenses Universal Donor Stem Cell Technology from...
PHOENIX AngioStemTM Inc. announced today signing of an exclusive licensing agreement with Queensland University covering intellectual property on newly discovered placentally derived stem cell...
View ArticleClik here to view.
Biosantech的抗HIV候选疫苗IIA期临床试验结果在《逆转录病毒学》上发表
法国索菲亚科技园 (美国商业资讯) — Biosantech的抗HIV候选疫苗IIA期临床试验主要目的是表明三联疗法暂停后，给予疫苗可降低病毒血症恢复及促病毒DNA，该试验的详细结果刚刚在科学期刊《逆转录病毒学》上发表。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View Article